시장보고서
상품코드
1954293

의료 워크플로우 최적화용 AI 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 컴포넌트별, 용도별, 전개 모드별, 최종 사용자별, 기능별, 솔루션별(-2035년)

AI for Healthcare Workflow Optimization Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Functionality, Solutions

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 386 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의료 워크플로우 최적화용 AI 시장은 2024년 26억 달러에서 2034년까지 79억 달러로 확대될 전망이며, CAGR 약 11.1%를 나타낼 것으로 예측됩니다. 의료 워크플로우 최적화용 AI 시장은 인공지능을 통해 의료 현장의 업무 효율을 향상시키는 솔루션을 포함하고 있습니다. 이러한 솔루션은 관리 업무를 효율화하고, 환자 일정을 개선하며, 자원 배분을 최적화합니다. 이 시장은 비용 절감의 필요성, 환자 케어의 향상, 의료 시스템의 디지털 전환에 의해 견인되고 있습니다. AI 기술의 진화에 따라 상호 운용성, 데이터 보안, 규제 준수에 초점을 맞춘 시장의 성장이 전망되고 있습니다.

의료 워크플로우 최적화용 AI 시장은 의료 업무의 효율화 요구에 힘입어 견조한 성장을 이루고 있습니다. 소프트웨어 분야가 가장 높은 성장률을 나타내고 임상 의사 결정 지원 시스템과 환자 관리 소프트웨어가 견인 역할을 하고 있습니다. 이 도구는 진단 정확도를 높이고 환자 관리 프로세스를 간소화합니다. 하드웨어 부문, 특히 AI 탑재 디바이스가 이에 이어 높은 성장률을 보이고 있습니다. 이 장비는 AI를 통합하여 진단 정확도 및 치료 결과를 향상시킵니다. AI를 활용한 관리 솔루션 수요도 높아지고 있어 의료기관에 있어서 스케줄 관리나 자원 배분을 최적화하고 있습니다. 머신러닝 알고리즘은 환자 예후 예측 및 업무 효율성 향상에 점점 더 많이 활용되고 있습니다. 원격 의료 플랫폼에 대한 AI 통합도 기세를 늘리고 원격 모니터링과 원격 진료를 제공합니다. 의료 제공업체가 비용 절감과 서비스 제공을 향상시키는 것을 목표로 하는 동안, 워크플로우 최적화에 있어서 AI 기술의 채용은 중요한 초점이며, 환자 케어 및 업무 성능의 대폭적인 개선이 기대되고 있습니다.

시장 세분화
유형별 예측 분석, 자연 언어 처리, 머신러닝, 딥러닝
제품별 소프트웨어 솔루션, 플랫폼, AI 기반 장치
서비스별 컨설팅 서비스, 통합, 구현, 지원, 유지보수, 트레이닝 및 교육
기술별 클라우드 기반, 온프레미스, 하이브리드
컴포넌트별 하드웨어, 소프트웨어, 서비스
용도별 임상 워크플로 최적화, 관리 업무 워크플로 최적화, 업무 워크플로 최적화, 환자 관리
전개 모드별 클라우드, 온프레미스, 하이브리드
최종 사용자별 병원, 진료소, 진단실험실, 제약 회사, 연구소
기능별 데이터 관리, 의사 결정 지원, 프로세스 자동화, 환자 참여
솔루션별 워크플로우 자동화, 데이터 분석, 리스크 관리, 리소스 할당

의료 워크플로우 최적화용 AI 시장은 시장 점유율 변동이 심해 온프레미스형 솔루션보다 클라우드 기반 솔루션이 대두되고 있는 특징이 있습니다. 이러한 변화는 의료 업무의 원활한 통합과 확장성에 대한 수요 증가에 크게 기여합니다. 가격 전략은 경쟁이 치열하고 효율성 및 환자 관리 개선을 약속하는 혁신적인 솔루션의 도입에 영향을 미칩니다. 신제품의 투입이 빈번히 행해지고 있어 의료 성과의 향상을 위한 AI 활용에 대한 업계의 대처가 반영되고 있습니다. 북미는 도입에 있어 계속 주도적 입장을 유지하고 있지만 아시아태평양의 신흥 시장이 급속히 몰리고 있습니다. 이 분야의 경쟁은 치열하고 IBM, Microsoft, Google 등 주요 기업들이 지속적으로 자사 제품을 강화하고 있습니다. 규제 상황은 매우 중요하며 유럽과 북미의 엄격한 정책이 시장 역학을 형성하고 있습니다. 이러한 규제 준수는 시장 진입과 확대에 필수적입니다. AI 기술의 진보와 의료의 디지털화 진전에 견인되어 시장은 성장의 기운이 높아지고 있습니다. 그러나 데이터 프라이버시에 대한 우려와 통합의 복잡성과 같은 문제는 여전히 존재하며 전략적 계획과 혁신이 요구되고 있습니다. 인공지능이 의료 워크 플로에 혁명을 가져다 주면 미래는 유망합니다.

주요 동향 및 촉진요인 :

의료 워크플로우 최적화용 AI 시장은 효율적인 의료 서비스에 대한 수요 증가와 AI 기술의 통합으로 견조한 성장을 이루고 있습니다. 주요 동향으로서 AI를 활용한 솔루션의 도입으로 관리 업무가 효율화되어 의료 종사자의 부담 경감과 환자 케어의 질 향상을 도모하고 있습니다. 이 동향은 만성 질환이 증가함에 따라 환자 수가 증가하는 동안 효율적인 워크플로우 관리가 요구됨에 따라 더욱 가속화되고 있습니다. 전자 의료기기(EHR)의 보급과 상호 운용성에 대한 필요성이 높아짐에 따라 기존 시스템에 원활하게 통합 가능한 AI 기반 솔루션에 대한 수요가 확대되고 있습니다. 또 다른 중요한 동향은 맞춤형 의료에 대한 주력입니다. AI를 활용하여 개별 환자 데이터를 기반으로 하는 치료를 맞춤화함으로써 치료 성과를 개선하고 자원 배분을 최적화할 수 있습니다. 게다가 자연언어처리(NLP) 기술의 지속적인 진보로 의료현장에서의 고급 데이터 분석과 의사결정 능력이 실현되고 있습니다. 환자의 요구를 예측하고 스케줄링을 최적화하여 업무 효율성을 높이는 AI 구동 예측 분석 도구를 개발할 수 있는 많은 기회가 있습니다. 또한 가치 기반 의료 모델로의 전환으로 의료 제공업체는 환자 결과를 향상시키면서 비용 절감을 실현하는 AI 솔루션의 도입을 강요하고 있습니다. 확장성과 적응성이 뛰어난 AI 기술을 제공하는 기업은 특히 의료 인프라가 급속히 진화하고 있는 지역에서 이러한 새로운 기회를 활용하는데 있어서 유리한 입장에 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

  • 거시경제 분석
  • 시장 동향
  • 시장 성장 촉진요인
  • 시장 기회
  • 시장 성장 억제요인
  • CAGR : 성장 분석
  • 영향 분석
  • 신흥 시장
  • 기술 로드맵
  • 전략적 프레임워크

제4장 부문 분석

  • 시장 규모 및 예측 : 유형별
    • 예측 분석
    • 자연언어처리
    • 머신러닝
    • 딥러닝
  • 시장 규모 및 예측 : 제품별
    • 소프트웨어 솔루션
    • 플랫폼
    • AI 탑재 디바이스
  • 시장 규모 및 예측 : 서비스별
    • 컨설팅 서비스
    • 통합 및 실장
    • 서포트 및 보수
    • 트레이닝 및 교육
  • 시장 규모 및 예측 : 기술별
    • 클라우드 기반
    • 온프레미스
    • 하이브리드
  • 시장 규모 및 예측 : 컴포넌트별
    • 하드웨어
    • 소프트웨어
    • 서비스
  • 시장 규모 및 예측 : 용도별
    • 임상 워크플로우 최적화
    • 관리 업무 워크플로우 최적화
    • 업무 워크플로우 최적화
    • 환자 관리
  • 시장 규모 및 예측 : 전개 모드별
    • 클라우드
    • 온프레미스
    • 하이브리드
  • 시장 규모 및 예측 : 최종 사용자별
    • 병원
    • 진료소
    • 진단실험실
    • 제약회사
    • 연구소
  • 시장 규모 및 예측 : 기능별
    • 데이터 관리
    • 의사결정 지원
    • 프로세스 자동화
    • 환자 참여
  • 시장 규모 및 예측 : 솔루션별
    • 워크플로우 자동화
    • 데이터 분석
    • 리스크 관리
    • 자원 배분

제5장 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카
  • 아시아태평양
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주
    • 대만
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 서브 사하라 아프리카
    • 기타 중동 및 아프리카

제6장 시장 전략

  • 수요 및 공급의 갭 분석
  • 무역 및 물류 상의 제약
  • 가격, 비용 및 마진의 동향
  • 시장 침투
  • 소비자 분석
  • 규제 개요

제7장 경쟁 정보

  • 시장 포지셔닝
  • 시장 점유율
  • 경쟁 벤치마킹
  • 주요 기업의 전략

제8장 기업 프로파일

  • Qure.ai
  • Aidoc
  • Viz.ai
  • Zebra Medical Vision
  • Tempus
  • Path AI
  • Freenome
  • Butterfly Network
  • Cure Metrix
  • Arterys
  • Caption Health
  • Aidence
  • Enlitic
  • Medy Match Technology
  • Deep Mind Health
  • Vizient
  • Rad Net
  • Suki AI
  • Proscia
  • Gauss Surgical

제9장 당사에 대해서

AJY 26.03.31

AI for Healthcare Workflow Optimization Market is anticipated to expand from $2.6 billion in 2024 to $7.9 billion by 2034, growing at a CAGR of approximately 11.1%. The AI for Healthcare Workflow Optimization Market encompasses solutions that enhance operational efficiency in healthcare settings through artificial intelligence. These solutions streamline administrative tasks, improve patient scheduling, and optimize resource allocation. The market is driven by the need for cost reduction, improved patient care, and the digital transformation of healthcare systems. As AI technologies evolve, the market is poised for growth, focusing on interoperability, data security, and regulatory compliance.

The AI for Healthcare Workflow Optimization Market is experiencing robust growth, propelled by the need for efficiency in healthcare operations. The software segment is the top performer, with clinical decision support systems and patient management software leading the charge. These tools enhance diagnostic accuracy and streamline patient care processes. The hardware segment, particularly AI-enabled medical devices, follows as the second highest performing segment. These devices integrate AI for improved diagnostics and treatment outcomes. The demand for AI-driven administrative solutions is also rising, optimizing scheduling and resource allocation in healthcare facilities. Machine learning algorithms are increasingly utilized to predict patient outcomes and improve operational efficiency. The integration of AI in telemedicine platforms is gaining momentum, offering remote monitoring and consultations. As healthcare providers seek to reduce costs and enhance service delivery, the adoption of AI technologies in workflow optimization remains a critical focus, promising significant improvements in patient care and operational performance.

Market Segmentation
TypePredictive Analytics, Natural Language Processing, Machine Learning, Deep Learning
ProductSoftware Solutions, Platforms, AI-Powered Devices
ServicesConsulting Services, Integration and Implementation, Support and Maintenance, Training and Education
TechnologyCloud-Based, On-Premise, Hybrid
ComponentHardware, Software, Services
ApplicationClinical Workflow Optimization, Administrative Workflow Optimization, Operational Workflow Optimization, Patient Management
DeploymentCloud, On-Premises, Hybrid
End UserHospitals, Clinics, Diagnostic Laboratories, Pharmaceutical Companies, Research Institutes
FunctionalityData Management, Decision Support, Process Automation, Patient Engagement
SolutionsWorkflow Automation, Data Analytics, Risk Management, Resource Allocation

The AI for Healthcare Workflow Optimization market is characterized by a dynamic distribution of market share, with cloud-based solutions gaining prominence over on-premise alternatives. This shift is largely attributed to the growing demand for seamless integration and scalability in healthcare operations. Pricing strategies remain competitive, influenced by the introduction of innovative solutions that promise enhanced efficiency and patient care. New product launches are frequent, reflecting the industry's commitment to leveraging AI for improved healthcare outcomes. North America remains a leader in adoption, though emerging markets in Asia-Pacific are rapidly catching up. Competition in this sector is intense, with key players like IBM, Microsoft, and Google continuously enhancing their offerings. The regulatory landscape is pivotal, with stringent policies in Europe and North America shaping market dynamics. Compliance with these regulations is crucial for market entry and expansion. The market is poised for growth, driven by advancements in AI technologies and increased healthcare digitization. However, challenges such as data privacy concerns and integration complexities persist, necessitating strategic planning and innovation. The future is promising, with AI poised to revolutionize healthcare workflows.

Geographical Overview:

The AI for Healthcare Workflow Optimization Market is witnessing robust growth across diverse regions, each presenting unique opportunities. North America leads the charge, propelled by a strong healthcare infrastructure and substantial investments in AI-driven solutions. The region's focus on enhancing patient care and operational efficiency is a key driver. In Europe, the market is expanding, supported by government initiatives and a growing emphasis on healthcare digitization. The region's commitment to integrating AI into healthcare systems is fostering a dynamic ecosystem. Meanwhile, Asia Pacific is emerging as a significant growth pocket, driven by advancements in AI technologies and increasing healthcare demands. Countries like China and India are at the forefront, investing heavily in AI to streamline healthcare operations. Latin America and the Middle East & Africa are also gaining traction. Brazil and the UAE are notable for their strategic investments in AI to improve healthcare delivery, signaling promising growth potential.

Global tariffs and geopolitical tensions are significantly impacting the AI for Healthcare Workflow Optimization Market. Japan and South Korea, heavily reliant on advanced AI technologies, are diversifying supply chains to mitigate tariff-induced cost pressures and are investing in local R&D to enhance domestic capabilities. China's focus on self-reliance has intensified, with increased investment in indigenous AI technologies to circumvent export restrictions. Taiwan, pivotal in semiconductor manufacturing, navigates geopolitical uncertainties while maintaining its supply chain leadership. The parent market is witnessing robust growth, driven by the increasing demand for AI-driven healthcare solutions globally. By 2035, the market's evolution will hinge on strategic regional collaborations and supply chain resilience. Middle East conflicts, by impacting energy prices, could further influence operational costs and global supply chain stability.

Key Trends and Drivers:

The AI for Healthcare Workflow Optimization Market is experiencing robust growth, driven by escalating demand for efficient healthcare services and the integration of AI technologies. A key trend is the adoption of AI-powered solutions to streamline administrative tasks, reducing the burden on healthcare professionals and enhancing patient care delivery. This trend is further accelerated by the rising prevalence of chronic diseases, necessitating efficient workflow management to handle increasing patient volumes. The proliferation of electronic health records (EHRs) and the need for interoperability are driving the demand for AI-based solutions that can seamlessly integrate into existing systems. Another significant trend is the focus on personalized medicine, where AI is utilized to tailor treatments based on individual patient data, improving outcomes and optimizing resource allocation. Moreover, the ongoing advancements in natural language processing (NLP) are enabling more sophisticated data analysis and decision-making capabilities in healthcare settings. Opportunities abound in the development of AI-driven predictive analytics tools that can anticipate patient needs and optimize scheduling, thereby enhancing operational efficiency. Additionally, the shift towards value-based care models is prompting healthcare providers to adopt AI solutions that can improve patient outcomes while reducing costs. Companies that offer scalable and adaptable AI technologies are well-positioned to capitalize on these emerging opportunities, particularly in regions with rapidly evolving healthcare infrastructures.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Predictive Analytics
    • 4.1.2 Natural Language Processing
    • 4.1.3 Machine Learning
    • 4.1.4 Deep Learning
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software Solutions
    • 4.2.2 Platforms
    • 4.2.3 AI-Powered Devices
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting Services
    • 4.3.2 Integration and Implementation
    • 4.3.3 Support and Maintenance
    • 4.3.4 Training and Education
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Cloud-Based
    • 4.4.2 On-Premise
    • 4.4.3 Hybrid
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Workflow Optimization
    • 4.6.2 Administrative Workflow Optimization
    • 4.6.3 Operational Workflow Optimization
    • 4.6.4 Patient Management
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 Cloud
    • 4.7.2 On-Premises
    • 4.7.3 Hybrid
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Hospitals
    • 4.8.2 Clinics
    • 4.8.3 Diagnostic Laboratories
    • 4.8.4 Pharmaceutical Companies
    • 4.8.5 Research Institutes
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Data Management
    • 4.9.2 Decision Support
    • 4.9.3 Process Automation
    • 4.9.4 Patient Engagement
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Workflow Automation
    • 4.10.2 Data Analytics
    • 4.10.3 Risk Management
    • 4.10.4 Resource Allocation

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Functionality
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Functionality
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Functionality
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Qure.ai
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Aidoc
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Viz.ai
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Zebra Medical Vision
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Tempus
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Path AI
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Freenome
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Butterfly Network
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Cure Metrix
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Arterys
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Caption Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Aidence
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Enlitic
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Medy Match Technology
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Deep Mind Health
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Vizient
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Rad Net
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Suki AI
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Proscia
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Gauss Surgical
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제